Pneumagen

1 follower


Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.

Industries

+1

Headquarters

Employees

Links

Org chart

Douglas Thomson
Chief Executive Officer

Douglas Thomson

Collapse
David Brady
Head of BD
John Beadle
Non Executive Director
Mingkui Zhou
Head Of Research